APSR2026-382

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-034
P111
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1198377-46904-APSR-382_439662.pdf
Format: PDF Only
16. Interstitial Lung Disease
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Sugeesha Wickramasinghe * Royal Preston Hospital Respiratory Physician Preston United Kingdom
Alison Wylie - Royal Preston Hospital Respiratory Physician Preston United Kingdom
Yussef Haider - Royal Preston Hospital Respiratory Physician Preston United Kingdom
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Sugeesha
Wickramasinghe
sugeesha@gmail.com
+447459038508
31-40
Sri Lanka
Case Report
Atezolizumab-Induced Sarcoid-Like Reaction Mimicking Metastases in Metastatic Bladder Cancer: A Diagnostic Challenge
Maximum 25 words
Abstract Content
 
 
 
 
Drug-induced sarcoid-like reactions (SLRs) with pulmonary manifestations are uncommon but increasingly recognized with the expanding use of immune checkpoint inhibitors. These reactions may closely mimic metastatic disease, creating significant diagnostic uncertainty. Early recognition is essential, as withdrawal of the offending agent is often required.
A 64-year-old man with locally advanced, inoperable bladder cancer was treated with radiotherapy and atezolizumab. Surveillance CT imaging demonstrated new mediastinal lymphadenopathy, pulmonary nodules, and supraclavicular lymph node enlargement, raising concern for metastatic progression. Clinically, he reported exertional breathlessness, limited to walking half a mile on flat ground, and episodic chest pain without cough or cutaneous manifestations. Endobronchial ultrasound-guided lymph node aspiration revealed non-caseating granulomatous inflammation with no evidence of malignancy. Serum angiotensin-converting enzyme levels were significantly elevated, while bone profile, renal function, and echocardiography were normal. In the absence of histological evidence of metastases, an atezolizumab-induced sarcoid-like reaction was suspected. A change in immunotherapy was recommended, and imaging surveillance continued. Due to progressive radiological changes, corticosteroid therapy was initiated.
Immunotherapy-induced SLRs are increasingly reported but may be mistaken for disease progression, particularly in patients with lymphadenopathy and pulmonary nodules. Histological confirmation is crucial to avoid misdiagnosis and inappropriate oncologic management. Correlating symptom onset with immunotherapy initiation supports diagnosis. Early identification and withdrawal of the causative agent remain the cornerstone of management.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Sarcoid, Bladder cancer, Atezolizumab
maximum 3 keywords and no abbreviations, separated by commas
 
216